A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Xencor, Inc.
Medicenna Therapeutics, Inc.
University Health Network, Toronto
Carisma Therapeutics Inc
Light Chain Bioscience - Novimmune SA
Salubris Biotherapeutics Inc
Eli Lilly and Company
Xencor, Inc.